Lack of Epstein-Barr virus- and HIV-specific CD27 - CD8+ T cells is associated with progression to viral disease in HIV-infection

AIDS

Volumn 16, Issue 15, 2002, Pages 2001-2011

  Van Baarle, Debbie ^a   Kostense, Stefan ^a   Hovenkamp, Egbert ^a   Ogg, Graham ^a   Nanlohy, Nening ^a   Callan, Margaret F C ^a   Dukers, Nicole H T M ^a   McMichael, Andrew J ^a   Van Oers, Marinus H J ^a   Miedema, Frank ^a  

^a CENTRAL LABORATORY   (Netherlands)

Author keywords

CD27; CD8+ T cells; Disease progression; Epstein Barr virus; HIV

Indexed keywords

CD27 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; ANTIGENS, CD27; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; HERPESVIRUS 4, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPHENOTYPING; INTERFERON TYPE II; LYMPHOMA, AIDS-RELATED; MALE; MIDDLE AGED;

EID: 0037131304     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200210180-00004     Document Type: Article

References (40)

1. Doherty PC, Christensen JP. Accessing complexity: the dynamics of virus-specific T cell responses. Annu Rev Immunol 2000, 18:561-592.
2. Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996, 272:54-60.
3. Schmitz JE, Kuroda MJ, Santra S, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999, 283:857-860.
4. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996, 4:25-36.
5. Slifka MK, Whitton JL. Activated and memory CD8+ T cells can be distinguished by their cytokine profiles and phenotypic markers. J Immunol 2000, 164:208-216.
6. Ogg GS, Jin X, Bonhoeffer S, et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998, 279:2103-2106.
7. Ogg G, Kostense S, Klein MR, et al. Longitudinal phenotypic analysis of human immunodeficiency virus type 1-specific T lymphocytes: correlation with disease progression. J Virol 1999, 73:9153-9160.
8. Callan MFC, Tan L, Annels N, et al. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 1999, 187:1395-1402.
9. Jin X, Demoitie MA, Donahoe S, et al. High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfections. J Infect Dis 2000, 181:165-175.
10. Klein MR, Van Baalen CA, Holwerda AM, et al. Kinetics of Gag-specific CTL responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 1995, 181:1365-1372.
11. Kersten MJ, Van Gorp J, Pals ST, Boon F, Van Oers MHJ. Expression of Epstein-Barr virus latent genes and adhesion molecules in AIDS-related non-Hodgkin's lymphomas: correlation with histology and CD4-cell number. Leuk Lymphoma 1998, 30:515-524.
12. Kersten MJ, Klein MR, Holwerda AM, Miedema F, Van Oers MHJ. EBV-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressiong to opportunistic infection or non-Hodgkin's lymphoma. J Clin Invest 1997, 99:1525-1533.
13. Hamann D, Baars PA, Rep MHG, et al. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 1997, 186:1407-1418.
14. Hintzen R, de Jong R, Lens SMA, Brouwer M, Baars P, Van Lier RAW. Regulation of CD27 expression on subsets of mature T lymphocytes. J Immunol 1993, 151:2426-2435.
15. Akbar AN, Terry L, Timms A, Beverley PC, Janossy G. Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J Immunol 1988, 140:2171-2178.
16. Okumura M, Fujii Y, Inada K, Nakahara K, Matsuda H. Both CD45RA+ and CD45RA- sunpopulations of CD8+ T cells contain cells with high levels of lymphocyte function-associated antigen-1 expression, a phenotype of primed T cells. J Immunol 1993, 150:429-437.
17. Hamann D, Roos MThL, Van Lier RAW. Faces and phases of human CD8+ T cell development. Immunol Today 1999, 20:177-180.
18. Hamann D, Kostense S, Wolthers KC, et al. Evidence that human CD8+ CD45RA+CD27- cells are induced by antigen and evolve through extensive rounds of division. Int Immunol 1999, 11:1027-1033.
19. Bachmann MF, Barner M, Viola A, Kopf M. Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection. Eur J Immunol 1999, 29:291-299.
20. Kern F, Khatamzas E, Surel I, et al. Distribution of human CMV-specific memory T cells among the CD8+ subsets defined by CD57, CD27, and CD45 isoforms. Eur J Immunol 1999, 29:2908-2915.
21. Appay V, Nixon DF, Donahoe SM, et al. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000, 192:63-76.
22. Roos MThL, Van Lier RAW, Hamann D, et al. Changes in the composition of circulating CD8+ T cell subsets during acute Epstein-Barr virus and human immunodeficiency virus infection in man. J Infect Dis 2000, 182:451-458.
23. He XS, Rehermann B, Lopez-Labrador FX, et al. Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci USA 1999, 96:5692-5697.
24. Shankar P, Russo M, Harnisch B, Patterson M, Skolnik P, Lieberman J. Impaired function of circulating HIV-specific CD8+ T cells in chronic human immunodeficiency virus infection. Blood 2000, 96:3094-3101.
25. Altman JD, Moss PAH, Goulder PJR, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996, 274:94-96.
26. van Baarle D, Hovenkamp E, Callan MFC, et al. Dysfunctional Epstein-Barr virus (EBV)-specific CD8+ T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin's lymphoma. Blood 2001, 98:146-155.
27. Kostense S, Ogg GS, Manting EH, et al. High viral burden in the presence of major HIV-specific CD8+ T cell expansions: evidence for impaired T cell effector function. Eur J Immunol 2001, 31:677-686.
28. Lalvani A, Brookes R, Hambleton S, Britton WJ, Hill AVS, McMichael AJ. Rapid effector function in CD8+ memory T cells. J Exp Med 1997, 186:859-865.
29. De Jong R, Brouwer M, Hooibrink B, Van der Pouw Kraan TCTM, Miedema F, Van Lier RAW. The CD27- subset of peripheral blood memory CD4+ lymphocytes contains functionally differentiated T lymphocytes that develop by persistent antigenic stimulation in vivo. Eur J Immunol 1992, 22:993-999.
30. Mellors JW, Kingsley L, Rinaldo CR, Jr., et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995, 122:573-579.
31. Hislop AD, Gudgeon NH, Callan MFC, et al. EBV-specific CD8+ T cell memory: relationships beteween epitope specificity, cell phenotype, and immediate effector function. J Immunol 2001, 167:2019-2029.
32. Lechner F, Wong DK, Dunbar PR, et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000, 191:1499-1512.
33. Lee PP, Yee C, Savage PA, et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med 1999, 5:677-685.
34. Tan LC, Gudgeon N, Annels NE, et al. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J Immunol 1999, 162:1827-1835.
35. Rosenberg ES, Billingsley JM, Caliendo AM, et al. Vigorous HIV-1 specific CD4+ T cell responses associated with control of viremia. Science 1997, 278:1447-1450.
36. Kalams SA, Buchbinder SP, Rosenberg ES, et al. Association between virus-specific cytotoxic T-lymphocyte and helper responses in Human Immunodeficiency Virus type 1 infection. J Virol 1999, 73:6715-6720.
37. Pitcher CJ, Quittner C, Peterson DM, et al. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat Med 1999, 5:518-525.
38. Hintzen RQ, Lens SM, Beckmann MP, Goodwin RG, Lynch D, van Lier RA. Characterization of the human CD27 ligand, a novel member of the TNF gene family. J Immunol 1994, 152:1762-1773.
39. Lens SM, Baars PA, Hooibrink B, van Oers MH, van Lier RA. Antigen-presenting cell-derived signals determine expression levels of CD70 on primed T cells. Immunology 1997, 90:38-45.
40. Thorley-Lawson DA, Babcock GJ. A model for persistent infection with Epstein-Barr virus: the stealth virus of human B cells. Life Sci 1999, 65:1433-1453.